(Q34663554)

English

DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial (English)

1 reference

Europe PubMed Central

3 August 2017

1 reference

based on heuristic

inferred from title

John R. Mascola

8

object named as

John R Mascola

1 reference

Europe PubMed Central

3 August 2017

12

object named as

Gary J Nabel

1 reference

Europe PubMed Central

3 August 2017

Barney S. Graham

1

object named as

Barney S Graham

1 reference

Europe PubMed Central

3 August 2017

Julie Ledgerwood

6

object named as

Julie E Ledgerwood

1 reference

Europe PubMed Central

3 August 2017

10

object named as

Mario Roederer

1 reference

Europe PubMed Central

3 August 2017

2

object named as

Mary E Enama

1 reference

Europe PubMed Central

3 August 2017

Ingelise J Gordon

4

object named as

Ingelise J Gordon

1 reference

Europe PubMed Central

3 August 2017

11

object named as

Richard A Koup

1 reference

Europe PubMed Central

3 August 2017

3

object named as

Martha C Nason

1 reference

Europe PubMed Central

3 August 2017

author name string

Sheila A Peel

5

1 reference

Europe PubMed Central

3 August 2017

Sarah A Plummer

7

1 reference

Europe PubMed Central

3 August 2017

Robert T Bailer

9

1 reference

Europe PubMed Central

3 August 2017

VRC 008 Study Team

13

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

8 April 2013

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

8

1 reference

Europe PubMed Central

3 August 2017

4

1 reference

Europe PubMed Central

3 August 2017

e59340

1 reference

Europe PubMed Central

3 August 2017

copyright license

Creative Commons CC0 License

8 April 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

Electroporation delivery of DNA vaccines: prospects for success

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

DNA vaccines: a safe and efficient platform technology for responding to emerging infectious diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

Broad HIV-1 neutralization mediated by CD4-binding site antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

Genetic immunization by jet injection of targeted pDNA-coated nanoparticles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

Unsafe injections in the developing world and transmission of bloodborne pathogens: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

Hepatitis B vaccine administration: comparison between jet-gun and syringe and needle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3620125

7 July 2018

Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0059340

21 January 2018

Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0059340

21 January 2018

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/23577062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasmid DNA vaccines: tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/23577062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23577062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can needle-free administration of vaccines become the norm in global immunization?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23577062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity and safety of a new inactivated hepatitis A vaccine: a clinical trial with comparison of administration route

1 reference

https://pubmed.ncbi.nlm.nih.gov/23577062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/23577062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis A vaccine administration: comparison between jet-injector and needle injection

1 reference

https://pubmed.ncbi.nlm.nih.gov/23577062

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0059340

1 reference

Europe PubMed Central

3 August 2017

2013PLoSO...859340G

0 references

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34663554&oldid=1954899323"